Abstracts Archive - Page 540 of 1683 - ATC Abstracts

2020 American Transplant Congress
Transplant Surgery Continuing Professional Development Courses Increase Knowledge and Procedural Confidence
M. J. Hobeika¹, T. Menser², A. Kassam³, T. C. Rice⁴, T. S. Diwan³
¹Houston Methodist Hospital, Houston, TX, ²Houston Methodist Research Institute, Houston, TX, ³University of Cincinnati Medical Center, Cincinnati, OH, ⁴Washington University, St. Louis, MO
*Purpose: Continuing professional development (CPD) workshops are emerging to fill critical knowledge and skill gaps in both surgical trainees and practicing surgeons. The ASTS has…
2020 American Transplant Congress
Characterizing the Waitlist Candidate Who Was Bypassed by the Successfully Transplanted Candidate with Alcoholic Hepatitis
J. Ge¹, C. L. Berg², F. Y. Yao¹, J. P. Roberts³, J. C. Lai¹
¹Medicine - Gastroenterology, University of California, San Francisco, San Francisco, CA, ²Duke University, Durham, NC, ³Surgery, University of California, San Francisco, San Francisco, CA
*Purpose: Early liver transplantation (LT) for acute alcoholic hepatitis (AH) has increased dramatically in the US since 2016. Due to high MELD-Na scores, AH candidates…
2020 American Transplant Congress
Quantifying Gender-Based Disparties in Liver Allocation: A Path Forward
B. A. Shelton¹, K. Olthoff², E. Pomfret³, K. A. Forde², D. Sawinski⁴, M. Gray¹, N. Ascher⁵, J. E. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, ³University of Colorado School of Medicine, Denver, CO, ⁴University of Pennsylvania, Philadelphia, PA, ⁵University of California at San Francisco School of Medicine, San Francisco, CA
*Purpose: Differences in local organ supply and demand have introduced geographic inequities in the Model for End-stage Liver Disease (MELD) based liver allocation system prompting…
2020 American Transplant Congress
Selectively Transplanting Moderately to Severely Macrosteatotic Grafts: Does Recipient Metabolic Environment Affect Outcomes?
P. J. Altshuler, A. Rios Diaz, O. Shaheen, A. P. Shah, W. R. Maley, A. Frank, C. Ramirez, J. Glorioso, H. Dang, A. S. Bodzin
Department of Surgery, Thomas Jefferson University, Philadelphia, PA
*Purpose: As incidence of Non-Alcoholic Steatohepatitis (NASH) cirrhosis rises, organ utilization remains stagnant. Recently, it has been shown that selective utilization of >30% macrosteatotic grafts…
2020 American Transplant Congress
HCV-Positive Donors Are Healthier and Inequitably Utilized in the United States
B. L. Da, T. Kushner, G. Kakked, J. Crismale, G. Ezaz, T. Schiano, B. Saberi
Liver Disease, Icahn School of Medicine at Mount Sinai, New York, NY
*Purpose: Increased utilization of HCV-positive (HCV+) liver allografts has been endorsed as a solution to the national organ shortage. Due to the opioid epidemic, there…
2020 American Transplant Congress
A Multi-Center Pilot and Feasibility Randomized Clinical Trial of a Home-Based Exercise Program for Patients with Cirrhosis: The Strength Training Intervention
J. C. Lai¹, M. R. Kappus², J. L. Dodge¹, R. Wong¹, Y. Mohamad¹, D. L. Segev³, M. A. McAdams-DeMarco⁴
¹University of California, San Francisco, San Francisco, CA, ²Duke University, San Francisco, NC, ³Johns Hopkins Medical Institute, Baltimore, MD, ⁴Johns Hopkins School of Public Health, Baltimore, MD
*Purpose: Patients with cirrhosis experience progressive physical frailty and functional decline that may ultimately lead to an increased risk of death. We developed the Strength…
2020 American Transplant Congress
Frailty is Strongly Associated with Self-Reported Symptom Burden among Patients with Cirrhosis Undergoing Evaluation for Liver Transplantation
L. X. Deng, K. E. Bischoff, D. S. Kent, D. L. O’Riordan, S. Z. Pantilat, J. C. Lai
University of California, San Francisco, San Francisco, CA
*Purpose: Among patients with cirrhosis, frailty has most commonly been measured using instruments that focus on malnutrition, muscle wasting, and functional impairment. Little is known…
2020 American Transplant Congress
2019 Refined Criteria for Cirrhotic Cardiomyopathy Predict Post Liver Transplant Cardiac Events
M. J. Izzy¹, A. Soldatova², X. Sun², M. Angirekula³, K. Mara⁴, G. Lin², K. Watt³
¹Gastroenterology and Hepatology, Vanderbilt University Medical Center, Nashville, TN, ²Cardiovascular Medicine, Mayo Clinic, Rochester, MN, ³Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, ⁴Health Sciences Research, Mayo Clinic, Rochester, MN
*Purpose: Cirrhotic cardiomyopathy (CCM) encompasses systolic ± diastolic dysfunction (DD) in patients with end stage liver disease in the absence of known cardiac disease. The…
2020 American Transplant Congress
Bacterial Infection in Compensated Cirrhosis Predicts Inpatient Mortality and Readmission with Decompensation
R. Rosenblatt¹, A. Jesudian¹, C. Lucero¹, A. Kaplan¹, R. S. Brown¹, V. Sundaram², B. Fortune¹
¹Weill Cornell Medicine, New York, NY, ²Cedars Sinai, Los Angeles, CA
*Purpose: Identify the impact of bacterial infection on inpatient mortality and new decompensation in hospitalized patients with compensated cirrhosis from a nationally representative database.*Methods: This…
2020 American Transplant Congress
Neoadjuvant Gem/Cis Followed by Transarterial Radioembolization for Locally Advanced iCCA with Intent for Curative Resection
T. Baker, J. Fung, D. Disabato, A. Pillai, O. Ahmed, A. Liao
Transplantation Institute, The University of Chicago, Chicago, IL
*Purpose: Locally advanced intrahepatic cholangiocarcinoma (LAiCCA) has a traditionally poor prognosis with few curative surgical options and a high incidence of postop recurrence. The intent…